Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.

Genetic testing and molecular biomarkers - 1 May 2017

Afilal Driss, Basselam Mohamed Amine, Brakez Zahra, Chouham Said, Brehm António, Izaabel El Hassan

Abstract excerpt

BACKGROUND: The polymorphic cytochrome P450 isoenzymes CYP2C9 and CYP2C19 are involved in the biotransformation of a wide variety of clinical drugs. Their major alleles occur with varying frequencies among different populations worldwide and have been associated with a varied capacity to degrade important therapeutic agents. This gives rise to important individual and interethnic variability in drug metabolism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Gene Frequency

Share to Genetics, Population

Share to Morocco

Share to Polymerase Chain Reaction

Share to Young Adult

Source

Identifiers

PMID: 28282224
DOI: 10.1089/gtmb.2016.0304

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.PMID 28282224Read ↗

Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia.Semantic proximity Read ↗

Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.Semantic proximity Read ↗

Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome P450 2C19 gene in six major ethnicities of Pakistan.Semantic proximity Read ↗

Impact of Genetic Polymorphisms in CYP2C9 and CYP2C19 on the Pharmacokinetics of Clinically Used DrugsSemantic proximity Read ↗

Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.Semantic proximity Read ↗

The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance.Semantic proximity Read ↗

Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).Semantic proximity Read ↗

Prevalence of five pharmacologically most important CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Srpska in Bosnia and Herzegovina.Semantic proximity Read ↗

Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance.Semantic proximity Read ↗

Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects.Semantic proximity Read ↗

Distribution of the major cytochrome P450 (CYP) 2C9 genetic variants in a Saudi population.Semantic proximity Read ↗

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.